Search for: "In re: Avandia Marketing Sales Practices & Products Liability Litigation"
Results 1 - 20
of 41
Sort by Relevance
|
Sort by Date
21 Jan 2023, 6:07 pm
I can help point you in the right direction for reputable marketing agencies if you need lead sources or looking to purchase retainers. [read post]
17 Jan 2017, 3:00 am
The District Court, however, noted that because the plaintiffs’ claims have suffered similar injuries arising out of the defendants’ manufacture, marketing, or sale of propoxyphene products as In re Avandia Mktg., Sales Practices & Prods. [read post]
9 Apr 2016, 8:58 am
In re Zoloft Prod. [read post]
3 Mar 2016, 5:19 am
Hall, “Regulating Direct-to-Consumer Advertising with Tort Law: Is the Law Finally Catching Up with the Market? [read post]
26 Feb 2016, 10:48 am
In In re Avandia Marketing & Sales Practices and Product Liability Litigation, No. 15-2145, 2016 WL 559216 (3d Cir. [read post]
25 Feb 2016, 2:39 pm
In In re Avandia Marketing, Sales Practices and Products Liability Litigation (Linda and John Schatz, appellants), -- Fed. [read post]
31 Dec 2015, 5:12 am
Full disclosure: Reed Smith is involved in Caplinger, so consider this entry a non-RS post.In re Celexa & Lexapro Marketing & Sales Practices Litigation, 779 F.3d 34 (1st Cir. 2015). [read post]
24 Dec 2015, 8:20 am
The legislature chose not to punish FDA-regulated activity, but the court nullified that legislative decision, with practically no discussion.In re Avandia Marketing, Sales Practices & Product Liability Litigation, 804 F.3d 633 (3d Cir. 2015). [read post]
7 Dec 2015, 5:30 am
With its decision in In re Avandia Marketing, Sales Practices & Prod. [read post]
25 Jun 2015, 5:00 am
Bayer, 922 N.E.2d 309, 318 (Ill. 2009).For similar reasons – the “learned intermediary rule” − the Pennsylvania Unfair Trade Practices & Consumer Protection law (“UTPCPL”) was interpreted as excluding prescription medical products in In re Avandia Marketing, Sales & Products Liability Litigation, 2013 WL 3486907 (E.D. [read post]
7 May 2015, 5:00 am
. the Court considers that ruling dispositive on the standing issue in this case.Id. at *2 (quoting In re Avandia Marketing, Sales Practices & Products Liability Litigation, 564 F. [read post]
16 Dec 2014, 6:00 am
See In re Avandia Marketing, Sales Practices and Products Liability Litig., 2014 U.S. [read post]
3 Nov 2014, 5:12 am
Conn. 2012); In re Meridia Products Liability Litigation, 328 F. [read post]
22 Aug 2014, 9:22 am
In In re Avandia Marketing, Sales Practices & Products Liability Litigation, 817 F. [read post]
7 Jan 2014, 9:22 am
See, e.g., In re Agent Orange Product Liab. [read post]
2 Jan 2014, 8:08 am
See, e.g., In re Agent Orange Product Liab. [read post]
27 Nov 2013, 8:00 pm
In re Avandia Marketing, Sales Practices and Product Liability Litigation, 2011 WL 13576, *12 (E.D. [read post]
21 Oct 2013, 1:57 pm
The plaintiff in In re Avandia Marketing, Sales Practices and Prods. [read post]
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 60 (1st Cir. 2013) – all of which also travel under the heading, In re Neurontin Marketing and Sales Practices Litigation. [read post]
5 Sep 2013, 12:24 pm
June 1, 2012); In re Avandia Marketing, Sales Practices & Products Liability Litigation, 817 F. [read post]
